CoChat

Human Hepatic Hepa RG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP 450 Activity/Metabolism and Significantly Outperform Standard HepG2/C3A Cells for Pharmaceutical and Therapeutic Applications

Open access
Nelson, Leonard J., Morgan, Katie, Treskes, Philipp, Samuel, Kay, Henderson, Catherine J., LeBled, Claire, Homer, Natalie, Grant, M. Helen, Hayes, Peter C., Plevris, John N. · 2017 · Basic & Clinical Pharmacology & Toxicology
Cited by 73

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Conventional in vitro human hepatic models for drug testing are based on the use of standard cell lines derived from hepatomas or primary human hepatocytes (PHH s). Limited availability, interdonor functional variability and early phenotypic alterations in PHH s restrict their use, whilst standard cell lines such as HepG2 lack a substantial and variable set of liver‐specific functions such as CYP 450 activity. Alternatives include the HepG2‐derivative C3A cells selected as a more differentiated and metabolically active hepatic phenotype. Human Hepa RG cells are an alternative organotypic co‐culture model of hepatocytes and cholangiocytes reported to maintain in vivo‐like liver‐specific functions, including intact Phase I–III drug metabolism. In this study, we compared C3A and human Hepa RG cells using phenotypic profiling, CYP 450 activity and drug metabolism parameters to assess their value as hepatic models for pre‐clinical drug testing or therapeutics. Compared with C3As, Hepa RG co‐cultures exhibit a more organotypic phenotype, including evidence of hepatic polarity with the strong expression of CYP 3A4, the major isoform involved in the metabolism of over 60% of marketed drugs. Significantly greater CYP 450 activity and expression of CYP 1A2, CYP 2E1 and CYP 3A4 genes in Hepa RG cells (comparable with that of human liver tissue) was demonstrated. Moreover, Hepa RG cells also preferentially expressed the hepatic integrin α 5 β 1 – an important modulator of cell behaviour including growth and survival, differentiation and polarity. Drug metabolite profiling of phenacetin (CYP 1A2) and testosterone (CYP 3A4) using LC‐MS/MS and HPLC, respectively, revealed that Hepa RG s had more intact (Phase I–II) metabolism profile. Thus, Hepa RG cells significantly outperform C3A cells for the potential pharmaceutical and therapeutic applications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bcpt.12631

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

Metadata

Authors
Nelson, L. J., Morgan, K., Treskes, P., Samuel, K., Henderson, C. J., LeBled, C., Homer, N., Grant, M. H., Hayes, P. C., & Plevris, J. N.
Venue
Basic & Clinical Pharmacology & Toxicology
Publisher
Wiley
Published
2016-07-15
Volume
120
Issue
1
Pages
30-37
ISSN
  • 1742-7835 (ISSN-L)
  • 1742-7843
OpenAlex
W2413965588
Cited by
73
References
2
FWCI
5.92
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.